In 2022, a multidisciplinary team in the Cardiac Center at CHOP implemented a specialized ventricular recovery program to encourage and identify patients who could benefit from heart recovery with ...

Field Medical, Inc., a clinical-stage medical technology company advancing pulsed field ablation (PFA) solutions for complex ...

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Who Is At Risk?. DEAR MAYO CLINIC: What is the difference between sudden cardiac arrest and a heart attack? Who is at risk for both, and what safety measures can we take? ANSWER: Sud ...

Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication ...

The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

Netherlands: A new cohort study published in JAMA has shown that existing thresholds for left ventricular remodeling may need ...

Dextrocardia with situs inversus is mostly benign, but highly peculiar ...

Alex Balmes thought it was anxiety causing his symptoms, but it was heart failure at 30. Here's what this young dad wants ...

A novel external artificial lung system sustained an adult man for approximately 2 days after his irreversibly diseased lungs ...